5HT-4/dopamine D2 antagonists (J&J)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5HT-4/dopamine D2 antagonists (J&J)
Drug Alias Name5HT-4/dopamine D2 dual antagonists (Johnson & Johnson)5HT-4/dopamine D2 dual antagonists (J&J)5HT-4/D2 dopamine dual antagonists (J&J)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsSerotonin 4 (5-HT4) receptor antagonists
TargetsSerotonin 4 (5-HT4) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A